Current issues with antibody-conjugated lipid nanoparticles

Current issues with antibody-conjugated lipid nanoparticles

Not available

Saved in:

Bibliographic Details
Main Author:	Aayush
Format:	Article
Language:	English
Published:	Bangabandhu Sheikh Mujib Medical University 2025-02-01
Series:	Bangabandhu Sheikh Mujib Medical University Journal
Subjects:	antibody-conjugated lipid nanoparticles nonviral gene delivery immunogenicity
Online Access:	https://banglajol.info/index.php/BSMMUJ/article/view/77310
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

1.4 nm gold nanoparticle-antibody conjugates for in situ gold immunolabelling after transduction into living human cells
by: Groysbeck, Nadja, et al.
Published: (2023-10-01)

Applications of liposomes and lipid nanoparticles in cancer therapy: current advances and prospects
by: Zhe Cheng, et al.
Published: (2025-01-01)

Formulation and characterization of solid lipid nanoparticles, nanostructured lipid carriers and nanoemulsion of lornoxicam for transdermal delivery
by: Gönüllü Ümit, et al.
Published: (2015-03-01)

Nonviral targeted mRNA delivery: principles, progresses, and challenges
by: Xi He, et al.
Published: (2025-01-01)

Lipid nanoparticles deliver DNA-encoded biologics and induce potent protective immunity
by: Dafei Chai, et al.
Published: (2025-01-01)

Antibody-epitope conjugates deliver immunogenic T-cell epitopes more efficiently when close to cell surfaces
by: W. van der Wulp, et al.
Published: (2024-12-01)

Doxorubicin-Conjugated Nanoparticles for Potential Use as Drug Delivery Systems
by: Alua Imantay, et al.
Published: (2025-01-01)

Enhancing the efficacy of near-infrared photoimmunotherapy through intratumoural delivery of CD44–targeting antibody–photoabsorber conjugatesResearch in context
by: Yuichi Adachi, et al.
Published: (2025-02-01)

Developability considerations for bispecific and multispecific antibodies
by: Alaa Amash, et al.
Published: (2024-12-01)

Impacts of genomic alterations on the efficacy of HER2-targeted antibody–drug conjugates in patients with metastatic breast cancer
by: Riqing Huang, et al.
Published: (2025-01-01)

Impact of HER2-targeting antibody drug conjugates in treatment strategies for patients with breast cancer
by: Hanghang Ma, et al.
Published: (2025-02-01)

Discovery of a novel highly specific, fully human PSCA antibody and its application as an antibody-drug conjugate in prostate cancer
by: Xiaojie Chu, et al.
Published: (2024-12-01)

Vector‐Free Deep Tissue Targeting of DNA/RNA Therapeutics via Single Capacitive Discharge Conductivity‐Clamped Gene Electrotransfer
by: Jeremy L. Pinyon, et al.
Published: (2025-01-01)

Labeling tumor-associated extracellular vesicles with antibody-DNA conjugates for quantitative analysis
by: Xiao Du, et al.
Published: (2025-01-01)

Innovative Solid Lipid Nanoparticle-Enriched Hydrogels for Enhanced Topical Delivery of L-Glutathione: A Novel Approach to Anti-Ageing
by: Mengyang Liu, et al.
Published: (2024-12-01)

Biparatopic antibodies: therapeutic applications and prospects
by: David L. Niquille, et al.
Published: (2024-12-01)

Innovative Lipid Nanoparticles Co-Delivering Hydroxychloroquine and siRNA for Enhanced Rheumatoid Arthritis Therapy
by: Yanru Feng, et al.
Published: (2025-01-01)

T and B cell epitope analysis for the immunogenicity evaluation and mitigation of antibody-based therapeutics
by: Ruoxuan Sun, et al.
Published: (2024-12-01)

Six events that shaped antibody approvals in oncology
by: Suman Paul, et al.
Published: (2025-02-01)

Utility of 131I-HLX58-Der for the Precision Treatment: Evaluation of a Preclinical Radio-Antibody-Drug-Conjugate Approach in Mouse Models
by: Liu Y, et al.
Published: (2025-01-01)

Targeted protein degradation through site-specific antibody conjugation with mannose 6-phosphate glycan
by: Kaori Mukai, et al.
Published: (2024-12-01)

Maytansinoids in cancer therapy: advancements in antibody–drug conjugates and nanotechnology-enhanced drug delivery systems
by: Matteo Perra, et al.
Published: (2025-01-01)

In silico methods for immunogenicity risk assessment and human homology screening for therapeutic antibodies
by: Aimee E. Mattei, et al.
Published: (2024-12-01)

Nanoparticle-mediated gene delivery techniques in plant systems
by: Kuber Shivashakarappa, et al.
Published: (2025-02-01)

Facilitating high throughput bispecific antibody production and potential applications within biopharmaceutical discovery workflows
by: Caitlin Fawcett, et al.
Published: (2024-12-01)

Silver nanoparticle induced immunogenic cell death can improve immunotherapy
by: Ara Sargsian, et al.
Published: (2024-11-01)

Nonclinical immunogenicity risk assessment for knobs-into-holes bispecific IgG1 antibodies
by: Wen-Ting K. Tsai, et al.
Published: (2024-12-01)

Electrostatic properties of human germlines and biodistribution of small biologics
by: Leticia Maria De Souza Cordeiro, et al.
Published: (2024-12-01)

Evolutionary and functional divergence of Sfx, a plasmid-encoded H-NS homolog, underlies the regulation of IncX plasmid conjugation
by: Avril Wang, et al.
Published: (2025-02-01)

Diethylene glycol monoethyl ether-mediated nanostructured lipid carriers enhance trans-ferulic acid delivery by Caco-2 cells superior to solid lipid nanoparticles
by: Zhang Hongyu, et al.
Published: (2023-03-01)

Peptide hydrogel-drug conjugates for tailored disease treatmentGuidelines to assemble peptide-based hydrogel-drug conjugates, referenced with a selection of relevant publications.
by: Thibault Cauwenbergh, et al.
Published: (2025-04-01)

Microplastics mediates the spread of antimicrobial resistance plasmids via modulating conjugal gene expression
by: Qiu E. Yang, et al.
Published: (2025-01-01)

Development of Spray-Dried Micelles, Liposomes, and Solid Lipid Nanoparticles for Enhanced Stability
by: Shradha Dattani, et al.
Published: (2025-01-01)

Revolutionizing acute myeloid leukemia treatment: a systematic review of immune-based therapies
by: Ugochi Ebinama, et al.
Published: (2025-01-01)

Development and Characterization of Lyophilized Chondroitin Sulfate-Loaded Solid Lipid Nanoparticles: Encapsulation Efficiency and Stability
by: Marta E. Bustos Araya, et al.
Published: (2025-01-01)

Single domain antibody-scFv conjugate targeting amyloid β and TfR penetrates the blood–brain barrier and interacts with amyloid β
by: Rebecca Faresjö, et al.
Published: (2024-12-01)

Pegylated NIR Fluorophore-Conjugated OBHSA Prodrug for ERα-Targeted Theranostics with Enhanced Imaging and Long-Term Retention
by: Xiaohua Wang, et al.
Published: (2025-01-01)

Production of antibodies and antibody fragments containing non-natural amino acids in Escherichia coli
by: Jacquelyn Blake-Hedges, et al.
Published: (2024-12-01)

Glycyrrhizinate Monoammonium Cysteine-Loaded Lipid Nanoparticles Allow for Improved Acute Liver Injury Therapy
by: Yunjie Xu, et al.
Published: (2025-01-01)

The combination of rAAV pseudo-lipid nanoparticle and triamcinolone acetonide enables multi-administration to liver
by: Chunmei Gan, et al.
Published: (2025-03-01)